Updates to the clinical testing requirements for Pompe disease, Gaucher disease (type 1) and MPS types I, II and VI

This document outlines the updates to the LSDP’s testing requirements for Pompe disease, Gaucher disease (type 1), and mucopolysaccharidosis types I, II, and VI arising from the LSDP Expert Panel’s Medicines Reviews Recommendations.

Downloads

Updates to the clinical testing requirements for Pompe disease, Gaucher disease (type 1) and MPS types I, II and VI

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Report
Audience:
General public
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.